Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients
- PMID: 1716542
- PMCID: PMC1535613
- DOI: 10.1111/j.1365-2249.1991.tb05752.x
Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients
Abstract
B cell subpopulations, as defined by double-labelling techniques with CD5 and CD19 monoclonal antibodies (MoAbs), were serially studied in 335 HIV-1 seropositive patients. At the time of the first consultation, no important modifications in either CD5+ or CD5- subpopulations were observed, whatever the stage of the disease. However, in 18 out of the 335 patients (5.37%), a sharp increase in B cells exceeding 20% and 300/mm3 was observed. This increase in B cells was mainly accounted for CD5-CD19+ B cell subpopulations and was associated with: (i) evolution of the disease, since only four patients presented it at their first consultation (one lymphadenopathy-associated syndrome (LAS) and three AIDS); (ii) advanced stages of disease since, at the time of B cell augmentation, two patients were staged as LAS, four as ARC and 12 as AIDS; (iii) a high incidence of non-Hodgkin's lymphomas (NHL) since three out of the 18 patients presented a histologically confirmed NHL and three others a clinical pattern compatible with this diagnosis. However, in three patients with B hyperlymphocytosis, polymerase chain reaction (PCR) studies of immunoglobulin gene rearrangement revealed the existence of a polyclonal expansion of B cells. These results justify inclusion of a pan-B cell marker in routine phenotypic studies of HIV-infected individuals, as well as the search for NHL among patients presenting this abnormality.
Similar articles
-
Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.Leuk Lymphoma. 1992 Jun;7(3):195-204. doi: 10.3109/10428199209053623. Leuk Lymphoma. 1992. PMID: 1282428 Clinical Trial.
-
Large-cell "mixed-phenotype" lymphoma in AIDS. Identification of a CD5-expressing subset of B-cell non-Hodgkin's lymphoma.Ann N Y Acad Sci. 1992 May 4;651:409-21. doi: 10.1111/j.1749-6632.1992.tb24641.x. Ann N Y Acad Sci. 1992. PMID: 1376058
-
CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease.Clin Immunol Immunopathol. 1993 Mar;66(3):260-8. doi: 10.1006/clin.1993.1034. Clin Immunol Immunopathol. 1993. PMID: 7679344
-
CD5 expression in human B-cell populations.Immunol Today. 1999 Jul;20(7):312-6. doi: 10.1016/s0167-5699(99)01476-0. Immunol Today. 1999. PMID: 10379049 Review.
-
CD5 negative IGM rheumatoid factor B cells in B-chronic lymphocytic leukemia and benign mixed cryoglobulinemia.Leuk Lymphoma. 1992 May;7(1-2):55-62. doi: 10.3109/10428199209053602. Leuk Lymphoma. 1992. PMID: 1282064 Review.
Cited by
-
Anti-phospholipid antibodies and CD5+ B cells in HIV infection.Clin Exp Immunol. 1999 Mar;115(3):464-71. doi: 10.1046/j.1365-2249.1999.00828.x. Clin Exp Immunol. 1999. PMID: 10193419 Free PMC article.
-
Prognostic significance of cytotoxic T cells in individuals infected with human immunodeficiency virus.J Clin Immunol. 1993 Mar;13(2):139-44. doi: 10.1007/BF00919270. J Clin Immunol. 1993. PMID: 7686562
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources